BiotechTube

Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + Placebo

Phase 2Completed
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Heartburn

Conditions

Heartburn

Trial Timeline

Dec 1, 2009 → —

NCT ID
NCT01037452

About Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + Placebo

Calcium carbonate/magnesium hydroxide/Lansoprazole 15 mg + Lansoprazole + Calcium carbonate/magnesium hydroxide + Placebo is a phase 2 stage product being developed by Novartis for Heartburn. The current trial status is completed. This product is registered under clinical trial identifier NCT01037452. Target conditions include Heartburn.

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01037452Phase 2Completed

Competing Products

20 competing products in Heartburn

See all competitors
ProductCompanyStageHype Score
rabeprazole sodiumEisaiPhase 3
77
rabeprazole sodium + placeboEisaiPhase 3
77
Rabeprazole sodiumEisaiPre-clinical
23
famotidine (+) calcium carbonate (+) magnesium hydroxide tablet + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet without water + Comparator: famotidine (+) calcium carbonate (+) magnesium hydroxide EZ Chew tablet with waterJohnson & JohnsonPhase 1
33
esomeprazole 40 mgAstraZenecaApproved
85
Esomeprazole magnesium (Nexium)AstraZenecaApproved
85
EsomeprazoleAstraZenecaPhase 3
77
EsomeprazoleAstraZenecaPhase 3
77
Esomeprazole + Lansoprazole + PantoprazoleAstraZenecaApproved
85
Esomeprazole Magnesium + LansoprazoleAstraZenecaApproved
85
Famotidine FCT + Famotidine CTMerckPhase 1
33
LanzoprazoleNovartisPhase 3
77
Lansoprazole + Lansoprazole + placeboNovartisPhase 3
77
LansoprazoleNovartisPhase 3
77
TegaserodNovartisPhase 3
77
Esomeprazole 20 mg + PlaceboPfizerApproved
84
bi-layer calcium carbonate tablet (BAY1180654) + Immediate release calcium carbonate tablet (BAY1180654)BayerPhase 1
30
omeprazole/sodium bicarbonate + omeprazole magnesiumBayerPhase 1
30
Talcid (Hydrotalcite, BAY4516H) + Famotidine + PlaceboBayerApproved
82
Omeprazole 20 mg + Sodium Bicarbonate 1100 mg + Omeprazole 20 mgBayerApproved
82

Other Products from Novartis

LCZ696Approved
85
zoledronic acidApproved
85
NateglinideApproved
85
TenofovirApproved
85
FTY720Approved
85